Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011.

Benn P, Borrell A, Cuckle H, Dugoff L, Gross S, Johnson JA, Maymon R, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y.

Prenat Diagn. 2012 Jan;32(1):1-2. doi: 10.1002/pd.2919. Epub 2012 Jan 24. No abstract available.

PMID:
22275335
2.

Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011.

Benn P, Borrell A, Crossley J, Cuckle H, Dugoff L, Gross S, Johnson JA, Maymon R, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y; International Society for Prenatal Diagnosis.

Prenat Diagn. 2011 Jun;31(6):519-22. doi: 10.1002/pd.2730. No abstract available.

PMID:
21604286
3.

Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.

Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, Gross S, Johnson J, Maymon R, Norton M, Odibo A, Schielen P, Spencer K, Huang T, Wright D, Yaron Y.

Prenat Diagn. 2013 Jul;33(7):622-9. doi: 10.1002/pd.4139. Epub 2013 May 21. No abstract available.

PMID:
23616385
4.

Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA.

Lun FM, Jin YY, Sun H, Leung TY, Lau TK, Chiu RW, Lo YM.

Clin Chem. 2011 Jun;57(6):917-9. doi: 10.1373/clinchem.2011.161844. Epub 2011 Mar 4. No abstract available.

5.

Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.

Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, Tang L, Hutchison D, Lu T, Wang H, Angkachatchai V, Oeth P, Cantor CR, Bombard A, van den Boom D.

Am J Obstet Gynecol. 2011 Mar;204(3):205.e1-11. doi: 10.1016/j.ajog.2010.12.060. Epub 2011 Feb 18.

PMID:
21310373
6.

Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly.

Benn P, Cuckle H, Pergament E.

Ultrasound Obstet Gynecol. 2012 Feb;39(2):127-30. doi: 10.1002/uog.11083. No abstract available.

7.

Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21.

Chiu RW, Sun H, Akolekar R, Clouser C, Lee C, McKernan K, Zhou D, Nicolaides KH, Lo YM.

Clin Chem. 2010 Mar;56(3):459-63. doi: 10.1373/clinchem.2009.136507. Epub 2009 Dec 21.

8.

Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies.

Boon EM, Faas BH.

Prenat Diagn. 2013 Jun;33(6):563-8. doi: 10.1002/pd.4111. Review.

PMID:
23613171
9.

[Prenatal diagnosis of genetic diseases: Lausanne experience 1989-1993].

Fokstuen S, Pescia G, Addor MC, Gaide AC, Marguerat P, Maillard C, Vial Y, Hohlfeld P, Nguyen The H.

Rev Med Suisse Romande. 1994 Dec;114(12):1055-65. Review. French. No abstract available.

PMID:
7817068
10.

Prevention of Down syndrome: the Jerusalem experience.

Bach G, Ben-Neriah Z, Sagi M.

Isr J Med Sci. 1993 Aug;29(8):468-70. No abstract available.

PMID:
7691779
11.

Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.

Kloza EM.

Birth Defects Orig Artic Ser. 1990;26(3):31-43. No abstract available.

PMID:
1709365
12.

[Prenatal diagnosis and screening for Down syndrome. The Danish Society of Medical Genetics].

Jensen PK.

Ugeskr Laeger. 2004 Mar 15;166(12):1115. Danish. No abstract available.

PMID:
15067774
13.

Ethnic differences in participation in prenatal screening for Down syndrome: a register-based study.

Fransen MP, Schoonen MH, Mackenbach JP, Steegers EA, de Koning HJ, Laudy JA, Galjaard RJ, Looman CW, Essink-Bot ML, Wildschut HI.

Prenat Diagn. 2010 Oct;30(10):988-94. doi: 10.1002/pd.2603.

PMID:
20799374
14.

Maternal serum screening for neural tube defects and Down syndrome.

Keith D.

Clin Lab Sci. 1992 Sep-Oct;5(5):274-6. No abstract available.

PMID:
10150964
15.

Maternal serum screening.

Lofsky S.

CMAJ. 1999 Apr 20;160(8):1125-6. No abstract available.

16.

Resources available for informed prenatal decisions.

Leach MW, Skotko BG.

Genet Med. 2012 Mar;14(3):348-9. doi: 10.1038/gim.2011.58. No abstract available.

PMID:
22391781
17.

Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.

Muller PR, Cocciolone R, Haan EA, Wilkinson C, Scott H, Sage L, Bird R, Hutchinson R, Chan A.

Am J Obstet Gynecol. 2007 Apr;196(4):315.e1-7; discussion 285-6.

PMID:
17403402
18.

On the current dilemma of Down syndrome screening.

Rose NC.

Obstet Gynecol. 2006 Jan;107(1):2-3. No abstract available.

PMID:
16394031
19.

First-trimester free beta (hCG) screening for Down syndrome.

Macri JN, Spencer K, Aitken D, Garver K, Buchanan PD, Muller F, Boue A.

Prenat Diagn. 1993 Jul;13(7):557-62.

PMID:
7692430
20.

[Possibilities of genetic counseling for prenatal diagnosis in pediatric practice].

Murken JD, Stengel-Rutkowski S, Zahn V, Jensen M.

Fortschr Med. 1979 Sep 13;97(34):1443-7. German. No abstract available.

PMID:
159245

Supplemental Content

Support Center